Papers - SAITO MANABU
-
Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese.(共著)
Yasui-Furukori N, Kaneda A, Iwashima K, Saito M, Nakagami T, Tsuchimine S, Kaneko S.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 144B ( 6 ) 724 - 727 2007.9
-
Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients.(共著)
Yasui-Furukori N, Tsuchimine S, Saito M, Nakagami T, Sato Y, Kaneko S.
Progress in Neuro-psychopharmacology and Biological Psychiatry. 31 ( 6 ) 1230 - 1234 2007.8
-
Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients.
Norio Yasui-Furukori, Shoko Tsuchimine, Manabu Saito, Taku Nakagami, Yasushi Sato, Sunao Kaneko
Progress in neuro-psychopharmacology & biological psychiatry 31 ( 6 ) 1230 - 4 2007.8
-
No association between CYP2D6 polymorphisms and personality trait in Japanese.（共著）
Iwashima K, Yasui-Furukori N, Kaneda A, Saito M, Nakagami T, Sato Y, Kaneko S.
British Journal of Clinical Pharmacology 64 ( 1 ) 96 - 99 2007.7
-
No association between CYP2D6 polymorphisms and personality trait in Japanese
Kumiko Iwashima, Norio Yasui-Furukori, Ayako Kaneda, Manabu Saito, Taku Nakagami, Yasushi Sato, Sunao Kaneko
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 64 ( 1 ) 96 - 99 2007.7
-
Different serum concentrations of steady-state valproic acid in two sustained-release formulations.(共著)
Yasui-Furukori N, Saito M, Nakagami T, Niioka T, Sato Y, Fujii A, Kaneko S.
Psychiatry and Clinical Neuroscience 61 ( 3 ) 308 - 312 2007.6
-
Different serum concentrations of steady-state valproic acid in two sustained-release formulations
Norio Yasui-Furukori, Manabu Saito, Taku Nakagami, Takenori Niioka, Yasushi Sato, Akira Fujii, Sunao Kaneko
PSYCHIATRY AND CLINICAL NEUROSCIENCES 61 ( 3 ) 308 - 312 2007.6
-
Dose-dependent interaction of paroxetine with riperidone in schizophrenic patients.
Saito M. Yasui-Furukori N, Nakagami T, Furukori H, Kaneko S
Journal of Clinical Psychopharmacology 25 527 - 532 2007.3
-
Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.（共著）
Yasui-Furukori N, Saito M, Niioka T, Inoue Y, Sato Y, Kaneko S.
Therapeutic Drug Monitoring 29 ( 1 ) 45 - 48 2007.2
-
Effect of itraconazole on pharmacokinetics of paroxetine: The role of gut transporters
Norio Yasui-Furukori, Manabu Saito, Takenori Niioka, Yoshimasa Inoue, Yasushi Sato, Sunao Kaneko
THERAPEUTIC DRUG MONITORING 29 ( 1 ) 45 - 48 2007.2
-
Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects.（共著）
Yasui-Furukori N, Saito M, Inoue Y, Niioka T, Sato Y, Tsuchimine S, Kaneko S.
European Journal of Clinical Pharmacology 63 ( 1 ) 51 - 6 2007.1
-
Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects.
Norio Yasui-Furukori, Manabu Saito, Yoshimasa Inoue, Takenori Niioka, Yasushi Sato, Shoko Tsuchimine, Sunao Kaneko
European journal of clinical pharmacology 63 ( 1 ) 51 - 6 2007.1
-
Overwhelming pneumococcal bacteremia revealed by a peripheral blood smear in a 74-year-old healthy woman.
Nakamura H, Saitou M, Kinjo S, Kaneshima H, Higa F, Tateyama M, Fujita J
Internal medicine (Tokyo, Japan) 46 ( 6 ) 303 - 6 2007
-
Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study.(共著)
Yasui-Furukori N, Saito M, Nakagami T, Kaneda A, Tateishi T, Kaneko S
Progress in Neuro-psychopharmacology and Biological Psychiatry. 30 ( 2 ) 286 - 291 2006.5
-
Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: A preliminary study
N Yasui-Furukori, M Saito, T Nakagami, A Kaneda, T Tateishi, S Kaneko
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 30 ( 2 ) 286 - 291 2006.3
-
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
Saito M, Yasui-Furukori N, Nakagami T, Furukori H, Kaneko S.
Journal of Clinical Psychopharmacology 25 ( 6 ) 527 - 532 2005.12
-
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients
M Saito, N Yasui-Furukori, T Nakagami, H Furukori, S Kaneko
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 25 ( 6 ) 527 - 532 2005.12
-
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition.（共著）
Nakagami T, Yasui-Furukori N, Saito M, Tateishi T, Kaneo S.
Clinical Pharmacology and Therapeutics 78 ( 1 ) 43 - 50 2005.7
-
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition
T Nakagami, N Yasui-Furukori, M Saito, T Tateishi, S Kaneo
CLINICAL PHARMACOLOGY & THERAPEUTICS 78 ( 1 ) 43 - 51 2005.7
-
Clinical pharmacogenetics in the treatment of schizophrenia
Manabu Saito, Norio Yasui-Furukori, Sunao Kaneko
Japanese Journal of Neuropsychopharmacology 25 ( 3 ) 129 - 135 2005.7